CLINICAL_TRIALS ClinicalTrials.gov record update

A Randomized, Double-blind, Parallel Group, Phase III Trial to Compare the Efficacy, Safety, and Immunogenicity of TX05 With Herceptin® in Subjects With HER2 Positive Early Breast Cancer

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT03556358
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:38:20.833877+00:00
Published At: 2022-01-14T00:00:00+00:00
Record Updated At: 2022-01-14
Results Posted At: 2022-01-14
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Breast Cancer", "Breast Neoplasms", "HER2-positive Breast Cancer", "Stage II Breast Cancer", "Stage IIIA Breast Cancer"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2022-01-14"
protocolSection.identificationModule.nctId: "NCT03556358"
protocolSection.identificationModule.officialTitle: "A Randomized, Double-blind, Parallel Group, Phase III Trial to Compare the Efficacy, Safety, and Immunogenicity of TX05 With Herceptin\u00ae in Subjects With HER2 Positive Early Breast Cancer"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2022-01-14"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.